Trial intelligence / Profile preview

Evaluation of treatment of actinic keratosis with hydrogen peroxide

IRCT20190928044912N1Phase 2Completed

Sponsor
Tehran University of Medical Sciences
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of hydrogen peroxide in actinic keratosis (AK), sponsored by Tehran University of Medical Sciences. Started Jul 2019; status: completed.

02

Drugs

hydrogen peroxide
03

Conditions

actinic keratosis (AK)

Beyond the preview

Go deeper on IRCT20190928044912N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190928044912N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call